app

Medicare for Renal Denervation; Cardiac Telemetry App Recall; Stroke Flags in Eyes

— Recent developments of interest in cardiovascular medicine

MedpageToday
Cardio Break over a computer rendering of a heart.

The Centers for Medicare & Medicaid Services will review a potential for patients with hypertension, Medtronic announced.

The FDA said Philips is recalling the monitoring service application used with and offering data reprocessing for some patients.

In the RESILIENT trial, did not significantly improve outcomes in older adults who went home after being hospitalized for ischemic heart disease. (JAMA Network Open)

In two studies, artificial intelligence (AI) models, trained on 12-lead electrocardiogram features, were able to predict in the general population and in patients with acute chest pain. (European Heart Journal)

AI was also able to predict risk of stroke using measurements from the in a U.K. Biobank cohort study. (Heart)

A , containing a statin and three half-dose antihypertensives, could be considered high-value for an underserved population, according to economic modeling. (JAMA Cardiology)

Among veterans, varied across the country by race and ethnicity, suggesting that areas with low rates of hypertension control would benefit from interventions to address disparities. (Journal of the American Heart Association)

For stroke patients with incomplete reperfusion after mechanical thrombectomy, adjunctive showed promise for getting them closer to complete recanalization in an observational pilot study. (Stroke)

A study showed that the changes to in the last decade have not benefited infants and children with cardiomyopathy or adults with congenital heart disease. (Circulation)

In a prespecified analysis of the FINEARTS-HF trial, heart failure patients who received finerenone (Kerendia) had an -- but it was not clear that this was a predictor of poor outcomes. (Journal of the American College of Cardiology)

There was also a reduced risk of associated with use of finerenone in another FINEARTS-HF analysis. (Lancet Diabetes & Endocrinology)

Among patients with end-stage heart failure and low pulmonary capillary wedge pressure, therapy was associated with milder but significant improvements in functional capacity and quality of life compared with those with high pulmonary capillary wedge pressure. (Circulation: Heart Failure)

An international study showed that the quality of care for patients with acute heart failure is worse in . (eClinicalMedicine)

Preclinical work suggested that cholesterol-lowering therapy can also dampen PIN1 activity, a driver of . (Cancer Discovery)

  • author['full_name']

    Nicole Lou is a reporter for app, where she covers cardiology news and other developments in medicine.